Table 5.
Parameter | Control group (n = 50) | Schizophrenic group (n = 50) | ||
---|---|---|---|---|
Non users (n = 32) | Users (n = 18) | Non users (n = 32) | Users (n = 18) | |
MDA (nmol/gmHb) | 0.045 ± 0.004 | 0.051 ± 0.005* | 0.056 ± 0.016 | 0.076 ± 0.014* |
GSH (mg/dl) | 43.83 ± 5.18 | 36.69 ± 4.43* | 36.37 ± 3.72 | 33.13 ± 3.42* |
Bilirubin (mg/dl) | 0.53 ± 0.07 | 0.48 ± 0.07** | 0.64 ± 0.13 | 0.61 ± 0.13NS |
Total Proteins (gm/dl) | 7.80 ± 0.33 | 7.89 ± 0.39NS | 6.48 ± 0.58 | 7.07 ± 0.73* |
Albumin (gm/dl) | 3.91 ± 0.44 | 4.25 ± 0.51*** | 3.71 ± 0.53 | 4.19 ± 0.31* |
Uric acid (mg/dl) | 3.86 ± 0.40 | 4.03 ± 0.46NS | 3.43 ± 0.48 | 3.20 ± 0.45* |
Comparison between non-users and users of control and schizophrenic groups. Values are mean ± SD
NS not significant
*p = 0.001; **p < 0.01;***p < 0.02